SPL 0.00% 9.5¢ starpharma holdings limited

Uk marketing with Amazon interesting, page-26

  1. 656 Posts.
    lightbulb Created with Sketch. 52
    The point is regardless of whether the product works the trial was a failure. A more highly powered study, a larger effect size, a different sample distribution etc etc could have changed that but claiming the current trial was successful is flat out wrong.

    I don't think there will ever be a properly powered clinical trial, the time where potential sales could have justified one has passed. That's just my opinion though. It's unfortunately a massive case of what could have been.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.